CoChat

Biopharmaceutic Classification System: A Scientific Framework for Pharmacokinetic Optimization in Drug Research

The DOI matches its Crossref record.

Abstract

The tenets of biopharmaceutics, solubility and permeability, are of pivotal importance in new drug discovery and lead optimization due to the dependence of drug absorption and pharmacokinetics on these two properties. A classification system for drugs based on these two fundamental parameters, Biopharmaceutic Classification System (BCS), provides drug designer an opportunity to manipulate structure or physicochemical properties of lead candidates so as to achieve better "deliverability". Considering the facts for failure of NCEs, drug research, once concentrating on optimizing the efficacy and safety of the leads, dramatically transformed in the past two decades. With the enormous number of molecules being synthesized using combinatorial and parallel synthesis, high throughput methodologies for screening solubility and permeability has gained significant interest in pharmaceutical industry. Ultimate aim of the drug discovery scientist in pharmacokinetic optimization is to tailor the molecules so that they show the features of BCS class I without compromising on pharmacodynamics. Considerations to optimize drug delivery and pharmacokinetics right from the initial stages of drug design propelled need for "High Throughput Pharmaceutics" (HTP). In silico predictions and development of theoretical profiles for solubility and lipophilicity provides structure based biopharmaceutical optimization, while in vitro experimental models (microtitre plate assays and cell cultures) validate the predictions. Thus, biopharmaceutical characterization during drug design and early development helps in early withdrawal of molecules with insurmountable developmental problems associated with pharmacokinetic optimization.

Overview

Integrity signals

Registry

Crossref · 10.2174/1389200043335423

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 119

Metadata

Authors
Varma, M., Khandavilli, S., Ashokraj, Y., Jain, A., Dhanikula, A., Sood, A., Thomas, N., Pillai, O., Sharma, P., Gandhi, R., Agrawal, S., Nair, V., & Panchagnula, R.
Affiliations
National Institute of Pharmaceutical Education and Research (IN)
Corresponding author
Panchagnula, Ramesh
Venue
Current Drug Metabolism
Published
2004-10-01
Volume
5
Issue
5
Pages
375-388
ISSN
1389-2002 (ISSN-L)
OpenAlex
W2001958300
Cited by
107
References
0
Citations by year
2026: 4 · 2025: 2 · 2024: 2 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 4 · 2018: 5 · 2017: 3 · 2016: 6 · 2015: 4 · 2014: 4 · 2013: 6 · 2012: 9
FWCI
4.53
Type
journal article
Language
en
Open access
closed
Locations
  • Current Drug Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
solubility, permeability, drug absorption, pharmacokinetic optimization, lead optimization, new chemical entities, high-throughput screening, lipophilicity prediction, structure-based drug design, in vitro permeability model
MeSH terms
Animals, Biopharmaceutics, Chemistry, Pharmaceutical, Pharmaceutical Preparations, Humans, Intestinal Absorption, Pharmacokinetics, Pharmacology, Clinical, Research, Solubility

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biopharmaceutic Classification System: A Scientific Framework for Pharmacokinetic Optimization in Drug Research. https://app.cochat.ai/papers/10.2174/1389200043335423
The paper
Varma, M., Khandavilli, S., Ashokraj, Y., Jain, A., Dhanikula, A., Sood, A., Thomas, N., Pillai, O., Sharma, P., Gandhi, R., Agrawal, S., Nair, V., & Panchagnula, R. (2004). Biopharmaceutic Classification System: A Scientific Framework for Pharmacokinetic Optimization in Drug Research. Current Drug Metabolism. https://doi.org/10.2174/1389200043335423

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.